Have liver function tests qualitive/quantative data, ALT AST levels in particular, viral load PCR quantity IU/ml of blood detectable HCV virus in patients’ blood stream been done for Ropren as these results may determine efficacy of treatment, and apparently are recognised worldwide in clinical trials as leading indicators. If so will/when are these results be announced?
Does this suffice?....
need more than the quarterly, page-43
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
